Pham Quang X
SEC CIK 1405290 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CVKD | Cadrenal Therapeutics, Inc. | COB, CEO, Interim CFO, Dir, 10% | 98.6K | $100.1K | $700.6K | 21 | 2023-02-10 | 2026-06-29 |
Most active insiders at CVKD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Pham Quang X | COB, CEO, Interim CFO, Dir, 10% | — | $630.3K |
| 2 | Szot Matthew K | CFO | — | $369.4K |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-07-01 21:52 | 2026-06-29 | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | COB, CEO, Dir, 10% | S - Sale | $3.03 | -7,400 | 98.6K | -7% | -$22.4K |
| MT | 2026-06-26 20:44 | 2026-06-25+ | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | COB, CEO, Interim CFO, Dir, 10% | S - Sale | $3.04 | -11.2K | 106.0K | -10% | -$33.9K |
| MT | 2026-06-24 17:15 | 2026-06-22+ | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | COB, CEO, Interim CFO, Dir, 10% | S - Sale | $3.48 | -11.4K | 117.1K | -9% | -$39.8K |
| MT | 2026-06-18 18:36 | 2026-06-16+ | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | COB, CEO, Interim CFO, Dir, 10% | S - Sale | $3.18 | -4,126 | 128.6K | -3% | -$13.1K |
| M | 2026-06-15 20:58 | 2026-06-11+ | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | COB, CEO, Interim CFO, Dir, 10% | S - Sale | $3.88 | -18.1K | 132.7K | -12% | -$70.4K |
| MT | 2026-06-10 20:26 | 2026-06-08+ | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | COB, CEO, Interim CFO, Dir, 10% | S - Sale | $4.17 | -22.4K | 150.8K | -13% | -$93.3K |
| MT | 2026-06-05 17:26 | 2026-06-03+ | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | CEO, COB, Dir, 10% | S - Sale | $4.37 | -8,285 | 173.2K | -5% | -$36.2K |
| MT | 2026-06-02 20:34 | 2026-05-29+ | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | CEO, COB, Dir, 10% | S - Sale | $4.72 | -652 | 181.5K | -0.4% | -$3,075 |
| MT | 2026-05-29 16:30 | 2026-05-11+ | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | CEO, COB, Dir, 10% | S - Sale | $5.44 | -12.8K | 182.2K | -7% | -$69.5K |
| T | 2026-05-26 21:06 | 2026-05-22 | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | CEO, COB, Dir, 10% | S - Sale | $5.69 | -1,165 | 194.9K | -0.6% | -$6,629 |
| M | 2025-10-28 | 2025-10-24+ | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | CEO, COB, Dir, 10% | S - Sale | $14.01 | -2,444 | 196.1K | -1% | -$34.2K |
| M | 2025-10-14 | 2025-10-09+ | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | CEO, COB, Dir, 10% | S - Sale | $14.09 | -3,600 | 200.3K | -2% | -$50.7K |
| 2025-10-03 | 2025-10-02 | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | CEO, COB, Dir, 10% | S - Sale | $14.13 | -500 | 202.1K | -0.2% | -$7,065 | |
| M | 2025-10-01 | 2025-09-29+ | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | CEO, COB, Dir, 10% | S - Sale | $14.01 | -1,300 | 203.5K | -0.6% | -$18.2K |
| M | 2025-09-26 | 2025-09-24+ | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | CEO, COB, Dir, 10% | S - Sale | $14.06 | -9,371 | 203.9K | -4% | -$131.8K |
| M | 2025-08-29 | 2025-08-27+ | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | CEO, COB, Dir, 10% | S - Sale | $13.99 | -5,029 | 213.3K | -2% | -$70.4K |
| 2024-04-10 | 2024-04-10 | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | CEO, COB, Dir, 10% | G - Gift | $0.00 | -50.0K | 3.27M | -2% | $0 | |
| 2024-02-12 | 2023-10-23 | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | CEO, COB, Dir, 10% | G - Gift | $0.00 | -85.0K | 3.33M | -2% | $0 | |
| M | 2023-09-06 | 2023-09-05 | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | CEO, COB, Dir, 10% | P - Purchase | $0.905 | +40.0K | 3.41M | +1% | +$36.2K |
| M | 2023-09-05 | 2023-09-01 | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | CEO, COB, Dir, 10% | P - Purchase | $0.9129 | +70.0K | 3.35M | +2% | +$63.9K |
| 2023-02-13 | 2023-02-10 | CVKD | Cadrenal Therapeutics, Inc. | Pham Quang X | CEO, COB, Dir, 10% | A - Grant | $1.94 | +25.0K | 3.30M | +0.8% | +$48.5K |
Purchase Sale Sale after option exercise All abbreviations